Javascript must be enabled for the correct page display
  • img
    search
    x
  • img
    CDMO Services
  • img
    TANVEX GLOBAL
  • img
    TWSE (6541) 51.90| $ TWD
  • About
    • Overview
    • Mission & Values
    • Our Journey
    • Leadership
    • Employee Stories
    Our mission is to make a positive contribution to humanity. We aim to improve the lives of people around the world by ensuring everyone has access to safe, effective, and affordable high-quality medicine — so they may live healthier days with their loved ones.
  • Products
    • Overview
    • Approved Products
    • Pipeline
    • Biosimilars
    • Pharmacovigilance
    We believe health is for everyone. We are building a pathway to help as many people as possible get access to safe, effective, and affordable high-quality medicine. Our products continue the fight against deadly diseases such as neutropenia and breast cancer.
  • News & Media
    • Press Releases
    • Media Resources
    Take a look at how we are impacting the world. Our news is your news as we continue our daily efforts to grant more patients access to safe, effective, and affordable high-quality medicine.
  • Resources
    • Brand to Biosimilar Database
    We aim to be a respected partner to our customers. We are proud to offer comprehensive patient support services designed to help simplify and support patient access — for every Tanvex product. And, as a service to the healthcare professionals we serve, Tanvex provides a live brand to biosimilar database for product reference purposes.
  • Careers
    • Why Tanvex
    • Benefits
    • Job Opportunities
    Come join our team. We are always looking for bright, motivated employees that share our vision to create a world where everyone has access to safe, effective, and affordable biopharmaceuticals.
  • Contact
    • GET IN TOUCH
    Reach out to us. We are ready to listen and help.
News

Take a look at how we are impacting the world.

All News

By Year:
  • Jul 8, 2024
    TX05 BLA Resubmisson
  • Jul 1, 2024
    Tanvex Received BLA Approval from FDA
  • Dec 29, 2023
    Tanvex BioPharma Elects Henry Chen as Chairman
  • Oct 17, 2023
    Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars
  • Jun 28, 2023
    Tanvex BioPharma Accelerates CDMO Layout to Expand Business Opportunities
preloader
PREVIOUS 1 2 3 NEXT
ALL NEWS
Follow Us
  • linkedin
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Return Goods Policy
  • Pharmacovigilance
  • Human Rights Statement
  • Labor Policy
  • Accessibility Statement